17-75920309-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001319193.2(FBF1):c.1795C>T(p.His599Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000366 in 1,611,282 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001319193.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBF1 | NM_001319193.2 | c.1795C>T | p.His599Tyr | missense_variant | 18/30 | ENST00000636174.2 | NP_001306122.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBF1 | ENST00000636174.2 | c.1795C>T | p.His599Tyr | missense_variant | 18/30 | 5 | NM_001319193.2 | ENSP00000490726.1 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152254Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000452 AC: 11AN: 243398Hom.: 0 AF XY: 0.0000375 AC XY: 5AN XY: 133248
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1458910Hom.: 0 Cov.: 32 AF XY: 0.0000165 AC XY: 12AN XY: 725638
GnomAD4 genome AF: 0.000184 AC: 28AN: 152372Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74512
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.1750C>T (p.H584Y) alteration is located in exon 17 (coding exon 16) of the FBF1 gene. This alteration results from a C to T substitution at nucleotide position 1750, causing the histidine (H) at amino acid position 584 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at